Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain

by Miller, Miles A., Moss, Marcia L., Powell, Gary, Petrovich, Robert, Edwards, Lori, Meyer, Aaron S., Griffith, Linda G., Lauffenburger, Douglas A.
Published 2015

CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro

by Hansen, Hinrich P., Trad, Ahmad, Dams, Maria, Zigrino, Paola, Moss, Marcia, Tator, Maximilian, Schön, Gisela, Grenzi, Patricia C, Bachurski, Daniel, Aquino, Bruno, Dürkop, Horst, Reiners, Katrin S, von Bergwelt-Baildon, Michael, Hallek, Michael, Grötzinger, Joachim, Engert, Andreas, Leme, Adriana F Paes, von Strandmann, Elke Pogge
Published 2016

ADAM8 as a drug target in Pancreatic Cancer

by Schlomann, Uwe, Koller, Garrit, Conrad, Catharina, Ferdous, Taheera, Golfi, Panagiota, Garcia, Adolfo Molejon, Höfling, Sabrina, Parsons, Maddy, Costa, Patricia, Soper, Robin, Bossard, Maud, Hagemann, Thorsten, Roshani, Rozita, Sewald, Norbert, Ketchem, Randal R., Moss, Marcia L., Rasmussen, Fred H., Miller, Miles A., Lauffenburger, Douglas A., Tuveson, David A., Nimsky, Christopher, Bartsch, Jörg W.
Published 2015